People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Integrated Environmental Technologies, Ltd. | — | Other | Seed | $4.8M | $56.3M | 2014 |
| Sulfagenix, Inc. | — | Biotechnology | Seed | $2.6M | $59.9M | 2014 |
| TheraVasc Inc. | — | Pharmaceuticals | Seed | $2.6M | $13.3M | 2009 |
Anthony Giordano at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony Giordano on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David LaVance | 1 | 4 |
| John Zak | 1 | 3 |
| Paul Clayson | 1 | 3 |
| John Huston | 1 | 2 |
| Susan Luria | 1 | 2 |
| David Harry | 1 | 1 |
| Valgene Dunham | 1 | 1 |
| Stewart William | 1 | 1 |
| Gabriel Gojon, Jr. | 1 | 1 |
| Cesar Vidales | 1 | 1 |
| William E. Prince | 1 | 1 |
| Marion C. Sofield | 1 | 1 |
| Kyle Chan | 1 | 1 |
| Michael Donnell | 1 | 1 |
| William Stuart | 1 | 1 |
| Raymond Kubacki | 1 | 1 |
| E. Wayne Kinsey | 1 | 1 |
| Thomas Gifford | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.